Weijie Li

Weijie Li

Auto-generated profile, based on publicly available information

Weijie Li

Children’s Mercy Kansas City

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Closed access
PDF file
WLWeijie Li
Weijie Li
RMRuth Morgan
Ruth Morgan
RNRoxanne Nieder
Roxanne Nieder
STSa Truong
Sa Truong
SHSahibu Sultan M. Habeebu
Sahibu Sultan M. Habeebu
AAAtif A. Ahmed
Atif A. Ahmed

3 May 2024 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Open access
PDF file
KDKatherine A. Devitt
Katherine A. Devitt
WKWolfgang Kern
Wolfgang Kern
WLWeijie Li
Weijie Li
XWXuehai Wang
Xuehai Wang
AWAllyson J. Wong
Allyson J. Wong
AIAndrea Illingworth
Andrea Illingworth
The assessment of T‐cell clonality by flow cytometry has long been suboptimal, relying on aberrant marker expression and/or intensity. The introduction of TRBC1 shows much promise for improving the diagnosis of T‐cell neoplasms in the clinical flow laboratory. Most laboratories considering this marker already have existing panels designed for T‐cell workups and will be determining how best to incorporate TRBC1. We present this comprehensive summary of TRBC1 and supplemental case examples to familiarize the flow cytometry community with its potential for routine application, provide examples of how to incorporate it into T‐cell panels, and signal caution in interpreting the results in certain diagnostic scenarios where appropriate.

26 July 2018 in Blood
Verified
Journal Article
Closed access
PDF file
WLWeijie Li
Weijie Li
KCKatherine Chastain
Katherine Chastain

21 January 2020 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
LZLei Zhang
Lei Zhang
LBLaura E Brown
Laura E Brown
LBLaurel M Bowen
Laurel M Bowen
LMLaura C McCarthy
Laura C McCarthy
LCLinda D Cooley
Linda D Cooley
WLWeijie Li
Weijie Li
Aims: Historically, there has been no consensus on the diagnostic classification of high-grade B-cell lymphoma (HGBCL) with morphological features of Burkitt lymphoma (BL) but no MYC gene rearrangement ( MYC -negative). The 2016 WHO classification of tumours of haematopoietic and lymphoid tissues has shed some light on this field with the modification of the grey-zone lymphoma with features intermediate between BL and diffuse large B-cell lymphoma, and the creation of several new entities. The aim of this study was to investigate how the revised WHO classification affects our practice in diagnosing these lymphomas in children. Methods: We retrospectively reviewed cases of mature HGBCL diagnosed at our hospital between 2015 and 2018. Results: Among 14 mature HGBCL cases with BL morphological features, 11 showed MYC rearrangement consistent with BL and 3 were MYC -negative. Two MYC -negative cases showed regions of 11q gain and loss by microarray consistent with Burkitt-like lymphoma with 11q aberration (BLL-11q). The third MYC -negative case showed diffuse and strong MUM1 expression, translocation involving 6p25 by chromosome analysis and IRF4 rearrangement by fluorescence in situ hybridisation analysis consistent with large B-cell lymphoma with IRF4 rearrangement (LBL-IRF4). All patients were treated according to applicable chemotherapeutic protocols and achieved remission. Conclusions: BLL-11q and LBL-IRF4, two newly defined entities, should be considered in paediatric MYC -negative mature HGBCL cases. Accurate diagnosis needs careful histopathological examination and proper cytogenetic testing. Since they have unique cytogenetic features, specific treatments for them may emerge in the future. Therefore, accurate diagnosis based on the 2016 WHO classification is clinically significant.

1 November 2018 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
WLWeijie Li
Weijie Li
DDDaniel Dim
Daniel Dim
LPLorien Paulson
Lorien Paulson
DRDouglas Rivard
Douglas Rivard
Aims Intrathyroidal ectopic thymus (ITET) is a rare cause of paediatric thyroid nodules. Although ultrasonography of ITET demonstrates a characteristic appearance similar to that of normal thymus, accurate differentiation from other thyroid nodule etiologies by ultrasonography is difficult, and so that fine needle aspiration (FNA) is usually performed for further analysis. The aim of this study was to evaluate the utility of flow cytometry (FCM) in confirming the diagnosis of ITET in thyroid FNA samples. Methods Five cases of ITET were retrieved from our thyroid FNA database within a 3-year period. Their clinical information, ultrasonographic features, cytology and FCM findings were retrospectively reviewed. The FCM results were compared with those of 22 T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma (T-ALL/LBL) cases. Results The FNA smears of all five ITET cases demonstrated abundant lymphocytes of variable sizes, which included some immature lymphoid cells. No Hassall’s bodies or atypical epithelioid cells were recognised. By multicolour FCM analysis including antibodies against CD1a, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD34, TDT and TCR, all ITET cases showed antigen expression patterns consistent with normal thymocyte maturation. All T-ALL/LBL cases exhibited significant immunophenotypic aberrancy. Conclusions The diagnosis of ITET based on FNA cytology is often inconclusive. The presence of immature lymphocytes often raises the concern for LBL. FCM with adequate antigen coverage can reliably distinguish ITET from T-ALL/LBL and make the diagnosis of ITET in FNA samples. Avoiding unnecessary further invasive procedures, providing reassurance to clinician and patient, the accurate diagnosis of ITET by FCM in FNA samples is clinically important.

26 July 2018 in Blood
Verified
Journal Article
Open access
PDF file
ARAida Ibricevic Richardson
Aida Ibricevic Richardson
WLWeijie Li
Weijie Li